Xencor reported $598K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Arrowhead Research ARWR:US USD 198K 0
AstraZeneca AZN:LN USD 387M 0
Biogen BIIB:US USD 100K 0
Cytokinetics CYTK:US USD 93K 8K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Novartis NOVN:VX USD 890M 0
Roche Holding ROG:VX 107M 53M
Seattle Genetics SGEN:US USD 185K 1000
Xencor XNCR:US USD 598K 0